Not only can the drug metformin help to effectively manage type 2 diabetes, but it may also give older women a better chance ...

Treating kidney disease GLP-1s show higher risk than SGLT2 inhibitors in kidney outcomes, but lower albuminuria and mortality rates.

NICE recommends SGLT-2 inhibitors with metformin at diagnosis, citing major cardiovascular, renal, and mortality benefits.

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a hormone called glucose-dependent insulinotropic polypeptide (GIP) to “help break ...

GLP-1 weight loss drugs have quickly moved from medical journals to household conversations, reshaping how Americans think about obesity, diabetes and weight loss. Headlines often describe them as ...

By Tarun Sai Lomte Widely used weight-loss and diabetes drugs show clear benefits, but emerging evidence clarifies their side effects, rare risks, and what clinicians should monitor long term. Review: ...

Now, it’s worth noting Stock Advisor’s total average return is 889 % — a market-crushing outperformance compared to 193% for the S&P 500. Don't miss the latest top 10 list, available with Stock ...

Breakthrough research shows diabetes medicine metformin may reduce age-related vision loss by 37%. Liverpool study offers hope for AMD treatment.

A US team has linked metformin use in older women with type 2 diabetes to a 30% lower risk of dying before 90. But does this hint at exceptional longevity or just better disease control? Could a cheap ...

District officials say the decision will save $12 million and will put Broward in line with other school districts.

Maryland’s Prescription Drug Affordability Board voted Monday to restrict the price that state and local employees will have to pay for two medicines for type 2 diabetes, Jaridance and Farxiga. The ...